Financials data is unavailable for this security.
View more
Year on year Elanco Animal Health Inc 's net income fell 1,478.21% from a loss of 78.00m to a larger loss of 1.23bn despite flat revenues.
| Gross margin | 55.19% |
|---|---|
| Net profit margin | -27.94% |
| Operating margin | -20.48% |
| Return on assets | -8.49% |
|---|---|
| Return on equity | -18.78% |
| Return on investment | -9.33% |
More ▼
Cash flow in USDView more
In 2023, Elanco Animal Health Inc did not generate a significant amount of cash. However, the company earned 271.00m from its operations for a Cash Flow Margin of 6.14%. In addition the company used 169.00m on investing activities and also paid 83.00m in financing cash flows.
| Cash flow per share | -1.18 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 12.02 |
|---|---|
| Tangible book value per share | -5.14 |
More ▼
Balance sheet in USDView more
| Current ratio | 2.93 |
|---|---|
| Quick ratio | 1.75 |
| Total debt/total equity | 0.9552 |
|---|---|
| Total debt/total capital | 0.4886 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -1,465.36%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -990.27 |
